Hemodialysis in the diabetic patient with end-stage renal disease

The Influence of Different Glucose Concentrations in Haemodialysis Solutions on Metabolism and Blood Pressure Stability in Diabetic Patients

In recent years the percentage of diabetic patients on haemodialysis has increased. Considering the high frequency of intradialytic hypotensive and hypoglycaemic episodes experienced by these patients, it was the aim of the present study to evaluate the influence of different dialysate glucose concentrations (5.5 mmol/L or 11 mmol/L) on blood pressure and glycaemic regulation, using special dialysis equipment - the GENIUS® System.

This cross-over, prospective and randomised study, total duration 14 weeks, included 20 diabetic patients on maintenance haemodialysis. Group 1: 9 patients dialysed using dialysate with a glucose concentration of 5.5 mmol/L and after 7 weeks switched to dialysate with a glucose concentration of 11 mmol/L. Group 2: vice versa.

Results show a statistically higher number of patients with hypoglycaemic and hypotensive episodes using dialysate with a 5.5 mmol/L glucose concentration. Also, mean serum glucose values were higher during haemodialysis sessions with a glucose dialysate concentration of 11 mmol/L. There were no statistical differences between the groups in laboratory values, HbA1C, insulin doses or in anthropometric parameters.

Our results suggest that fewer diabetic patients undergoing haemodialysis using a higher dialysate glucose concentration of 11 mmol/L have hypoglycaemic and hypotensive episodes. Since this dialysate glucose concentration had no influence on lipid or hepatic metabolism, anthropometric parameters and especially HbA1C values in this short-term study, the long term examination of its effects is warranted.

Primary Vascular Access Surgery in a Well Defined Geographical Region: Long-Term Results of Autogenous Arteriovenous Fistulas

Background and Aims:

Autogenous fistula should be constructed in a minimum of 50 of all new ESRD patients scheduled for haemodialysis. The radio-cephalic fistula described by Brescia and colleagues in 1966 is considered to be the access of choice due to its good patency and low complication rate. The aim of this study was to evaluate the outcome of primary access surgery in a well-defined geographical region in Finland.

Material and Methods:

All primary vascular access procedures between 1990–1999 were selected in the local vascular registry. Additional data was collected from patients' case records. Kaplan-Meier method was used to calculate fistula patency. Multivariate analysis of four variables (age, gender, diabetes mellitus, smoking) was done to determine their association with primary success

Results:

407 primary procedures were done during the 10-year period including 405 (99.5 %) autogenous fistulas and two prosthetic grafts (0.5 %). 230 (56.8 %) fistulas were used for haemodialysis during the study. Cumulative primary functional patency at one year was 84.1 %, at two years 75.2 % and at five years 50.1 %. An attempt to salvage failing or failed fistula was done in only 15 (6.5 %) cases with insignificant impact on outcome. None of the tested variables was associated with poor functional success.

Conclusions:

The strategy of using native radio-cephalic fistula as a first access site results in excellent early and long-term functional patency for ESRD patient.

Paired kidney donor exchanges and antibody reduction therapy: novel methods to ameliorate disparate access to living donor kidney transplantation in ethnic minorities

BACKGROUND

Currently ethnic minority patients comprise 60% of patients listed for kidney transplantation in the US; however, they receive only 55% of deceased donor renal transplants and 25% of living donor renal transplants. Ethnic disparities in access to kidney transplantation result in increased morbidity and mortality for minority patients with end-stage renal disease. Because these patients remain dialysis dependent for longer durations, they are more prone to the development of HLA antibodies that further delay the possibility of receiving a successful kidney transplant.

STUDY DESIGN

Two to 4 pretransplant and post-transplant plasma exchanges and i.v. immunoglobulin were used to lower donor-specific antibody levels to less than 1:16 dilution; cell lytic therapy was used additionally in some cases. Match pairing by virtual cross-matching was performed to identify the maximal exchange benefit. Sixty candidates for renal transplantation were placed into 4 paired kidney exchanges and/or underwent antibody reduction therapy.

RESULTS

Sixty living donor renal transplants were performed by paired exchange pools and/or antibody reduction therapy in recipients whose original intended donors had ABO or HLA incompatibilities or both (24 desensitization and 36 paired kidney exchanges). Successful transplants were performed in 38 ethnic minorities, of which 33 were African American. Twenty-two recipients were white. Graft and patient survival was 100% at 6 months; graft function (mean serum creatinine 1.4 g/dL) and acute rejection rates (20%) have been comparable to traditional live donor kidney transplantation.

CONCLUSIONS

Paired kidney donor exchange pools with antibody reduction therapy can allow successful transplant in difficult to match recipients. This approach can address kidney transplant disparities.

Haemodialysis vascular access and fistula surveillance methods in The Netherlands

INTRODUCTION

As the mean age of haemodialysis patients is increasing, fewer patients will have suitable blood vessels for the creation of a Brescia-Cimino fistula and an increased use of graft implants is to be expected.

METHODS

To assess the change in vascular access and the use of surveillance techniques, all haemodialysis centres in The Netherlands received a questionnaire regarding the types of vascular accesses and surveillance techniques used in their department on 31 December, 1996. The results were related to a comparable study done in 1987, shown between brackets.

RESULTS

The response of the haemodialysis staff was 96%, of the vascular surgeons this was 91%. Sixty-two per cent (70%) of the patients had Brescia-Cimino fistulas, 21% (13%) Polytetrafluoroethylene (PTFE) graft fistulas, 17% (17%) other vascular accesses. Scheduled surveillance for stenosis detection was done by recirculation measurements in 6%, venous pressure measurements in 31%, Duplex scanning in 11% and angiography in 11% of the centres. When access problems occurred, 79% of the physicians performed recirculation measurements, 38% venous pressure measurements, 79% Duplex scanning and 100% angiography. In 46% of the centres PTA was done occasionally, and in 46% routinely for the treatment of stenotic complications in arteriovenous fistulas.

CONCLUSIONS

The use of PTFE grafts and other types of vascular accesses has increased at the expense of BC fistulas. Recirculation and venous pressure measurements are primarily done when problems occur and not according to a standard surveillance schedule. For visualization of failing fistulas, 79% of the centres uses Duplex ultrasound analysis and 100% angiography. The popularity of PTA has increased from 46 to 92% of the centres.